Heartflow (HTFL) officer moves to sell 4,593 shares
Heartflow (HTFL) officer Vikram Verghese plans to sell 4,593 shares worth $230,743.50, acquired via a stock option exercise on June 10, 2024. The sale will be conducted under Rule 144 through Fidelity Brokerage Services LLC. As of September 14, 2026, 86,953,627 shares of common stock were outstanding.
How this was made
The 30-second read
Why it matters
Provides transparency on insider activity; minimal market impact due to modest size.
Market read
Small insider sale; limited relevance for traders.
What to watch
Potential tax planning or diversification motives unrelated to company fundamentals.
Background
Form 4 filing disclosed by SEC; standard regulatory disclosure of insider transactions.
Ticker impact
Officer Vikram Verghese filed a Form 4 to sell 4,593 shares (~$231K) under Rule 144.
No significant price movement expected.
The transaction size is small relative to float and market cap; typical for insiders.
Market effects
None; isolated insider transaction.
None; limited to Heartflow shareholders.
None
Counterpoint
Insider sell could hint at upcoming negative news, but size is too small to act on.
Key entities
- OfficerVikram Verghese
Heartflow officer selling shares.
- CompanyHeartflow, Inc.
Medical device company listed as HTFL.
